PMID- 25689462 OWN - NLM STAT- MEDLINE DCOM- 20151223 LR - 20181202 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 10 IP - 2 DP - 2015 TI - The acetate/ACSS2 switch regulates HIF-2 stress signaling in the tumor cell microenvironment. PG - e0116515 LID - 10.1371/journal.pone.0116515 [doi] LID - e0116515 AB - Optimal stress signaling by Hypoxia Inducible Factor 2 (HIF-2) during low oxygen states or hypoxia requires coupled actions of a specific coactivator/lysine acetyltransferase, Creb binding protein (CBP), and a specific deacetylase, Sirtuin 1 (SIRT1). We recently reported that acetylation of HIF-2 by CBP also requires a specific acetyl CoA generator, acetate-dependent acetyl CoA synthetase 2 (ACSS2). In this study, we demonstrate that ACSS2/HIF-2 signaling is active not only during hypoxia, but also during glucose deprivation. Acetate levels increase during stress and coincide with maximal HIF-2alpha acetylation and CBP/HIF-2alpha complex formation. Exogenous acetate induces HIF-2alpha acetylation, CBP/HIF-2alpha complex formation, and HIF-2 signaling. ACSS2 and HIF-2 are required for maximal colony formation, proliferation, migration, and invasion during stress. Acetate also stimulates flank tumor growth and metastasis in mice in an ACSS2 and HIF-2 dependent manner. Thus, ACSS2/CBP/SIRT1/HIF-2 signaling links nutrient sensing and stress signaling with cancer growth and progression in mammals. FAU - Chen, Rui AU - Chen R AD - Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America; Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing, China. FAU - Xu, Min AU - Xu M AD - Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America. FAU - Nagati, Jason S AU - Nagati JS AD - Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America. FAU - Hogg, Richard T AU - Hogg RT AD - Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America. FAU - Das, Alok AU - Das A AD - Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America. FAU - Gerard, Robert D AU - Gerard RD AD - Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America. FAU - Garcia, Joseph A AU - Garcia JA AD - Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America; Department of Medicine, Veterans Affairs North Texas Health Care System, Dallas, Texas, United States of America. LA - eng GR - I01 BX000446/BX/BLRD VA/United States GR - R01 HL108104/HL/NHLBI NIH HHS/United States GR - HL108104/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, U.S. Gov't, Non-P.H.S. DEP - 20150217 PL - United States TA - PLoS One JT - PloS one JID - 101285081 RN - 0 (Acetates) RN - 0 (Basic Helix-Loop-Helix Transcription Factors) RN - 0 (HIF1A protein, human) RN - 0 (Hypoxia-Inducible Factor 1, alpha Subunit) RN - 1B37H0967P (endothelial PAS domain-containing protein 1) RN - EC 2.3.1.48 (CREB-Binding Protein) RN - EC 2.3.1.48 (CREBBP protein, human) RN - EC 3.5.1.- (SIRT1 protein, human) RN - EC 3.5.1.- (Sirtuin 1) RN - EC 6.2.1.1 (ACSS2 protein, human) RN - EC 6.2.1.1 (Acetate-CoA Ligase) RN - IY9XDZ35W2 (Glucose) RN - S88TT14065 (Oxygen) SB - IM EIN - PLoS One. 2015;10(3):e0123612. PMID: 25823015 MH - Acetate-CoA Ligase/metabolism MH - Acetates/metabolism MH - Animals MH - Basic Helix-Loop-Helix Transcription Factors/*metabolism MH - CREB-Binding Protein/metabolism MH - Cell Line, Tumor MH - Disease Models, Animal MH - Glucose/metabolism MH - Humans MH - Hypoxia-Inducible Factor 1, alpha Subunit/metabolism MH - Mice MH - Oxygen/metabolism MH - *Signal Transduction MH - Sirtuin 1/metabolism MH - *Tumor Microenvironment PMC - PMC4331492 COIS- Competing Interests: The authors have declared that no competing interests exist. EDAT- 2015/02/18 06:00 MHDA- 2016/02/24 06:00 PMCR- 2015/02/17 CRDT- 2015/02/18 06:00 PHST- 2014/09/25 00:00 [received] PHST- 2014/12/10 00:00 [accepted] PHST- 2015/02/18 06:00 [entrez] PHST- 2015/02/18 06:00 [pubmed] PHST- 2016/02/24 06:00 [medline] PHST- 2015/02/17 00:00 [pmc-release] AID - PONE-D-14-42884 [pii] AID - 10.1371/journal.pone.0116515 [doi] PST - epublish SO - PLoS One. 2015 Feb 17;10(2):e0116515. doi: 10.1371/journal.pone.0116515. eCollection 2015.